Expression of α-synuclein, the precursor of non-amyloid β component of Alzheimer's disease amyloid, in human cerebral blood vessels

被引:56
作者
Tamo, W
Imaizumi, T [1 ]
Tanji, K
Yoshida, H
Mori, F
Yoshimoto, M
Takahashi, H
Fukuda, I
Wakabayashi, K
Satoh, K
机构
[1] Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Vasc Biol, Hirosaki, Aomori 0368562, Japan
[2] Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Mol Biol, Hirosaki, Aomori 0368562, Japan
[3] Taisho Pharmaceut Co Ltd, Med Res Labs, Mol Biol Lab, Omiya, Saitama 3308530, Japan
[4] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 9518585, Japan
[5] Hirosaki Univ, Sch Med, Dept Surg 1, Hirosaki, Aomori 0368562, Japan
基金
日本学术振兴会;
关键词
alpha-synuclein; endothelial cells; smooth muscle cells; amyloid beta; non-amyloid beta component; precursor of non-amyloid beta component; Parkinson's disease; Alzheimer's disease;
D O I
10.1016/S0304-3940(02)00297-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The non-amyloid beta component of Alzheimer's disease amyloid (NAC) is detected in cerebral amyloid angiopathy; and the precursor of NAC is now known to be identical to alpha-synuclein (alpha-S), a major component of Lewy bodies in Parkinson's disease. We studied if cerebral vascular cells express alpha-S. Immunohistochemical studies of human cerebral tissues from control and cerebral amyloid angiopathy patients revealed the expression of alpha-S in vascular endothelial and smooth muscle cells. Then we studied the expression of alpha-S in vitro using cultures of vascular cells. Cultures of human umbilical vein endothelial cells and umbilical artery smooth muscle cells were found to constitutively express alpha-S messenger RNA and protein. alpha-S is normally expressed in vascular cells and may play some physiological role in the vascular wall. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:5 / 8
页数:4
相关论文
共 21 条
  • [1] α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells
    Ancolio, K
    da Costa, CA
    Uéda, K
    Checler, F
    [J]. NEUROSCIENCE LETTERS, 2000, 285 (02) : 79 - 82
  • [2] Degradation of α-synuclein by proteasome
    Bennett, MC
    Bishop, JF
    Leng, Y
    Chock, PB
    Chase, TN
    Mouradian, MM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) : 33855 - 33858
  • [3] The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease
    Clayton, DF
    George, JM
    [J]. TRENDS IN NEUROSCIENCES, 1998, 21 (06) : 249 - 254
  • [4] Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions
    Giasson, BI
    Duda, JE
    Murray, IVJ
    Chen, QP
    Souza, JM
    Hurtig, HI
    Ischiropoulos, H
    Trojanowski, JQ
    Lee, VMY
    [J]. SCIENCE, 2000, 290 (5493) : 985 - 989
  • [5] Hashimoto M, 1999, BRAIN PATHOL, V9, P707
  • [6] α-synuclein promotes mitochondrial deficit and oxidative stress
    Hsu, LJ
    Sagara, Y
    Arroyo, A
    Rockenstein, E
    Sisk, A
    Mallory, M
    Wong, J
    Takenouchi, T
    Hashimoto, M
    Masliah, E
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (02) : 401 - 410
  • [7] Imaizumi T, 2000, THROMB HAEMOSTASIS, V83, P949
  • [8] THE PRECURSOR PROTEIN OF NON-A-BETA COMPONENT OF ALZHEIMERS-DISEASE AMYLOID IS A PRESYNAPTIC PROTEIN OF THE CENTRAL-NERVOUS-SYSTEM
    IWAI, A
    MASLIAH, E
    YOSHIMOTO, M
    GE, NF
    FLANAGAN, L
    DESILVA, HAR
    KITTEL, A
    SAITOH, T
    [J]. NEURON, 1995, 14 (02) : 467 - 475
  • [9] Jahroudi N, 1998, J NEUROSCI RES, V54, P828, DOI 10.1002/(SICI)1097-4547(19981215)54:6<828::AID-JNR11>3.0.CO
  • [10] 2-M